News
Sanofi Starts Work On €400 Million Smart Space In Singapore
Sanofi's "factory of the future" in Singapore could be operational by the middle of the decade. One of two so-called Evolutive Vaccine Facilities (EVFs) that the French drugmaker is building with a collective investment of 900 million euros (about...
News
NorthEdge invests in leading Life Sciences marketing specialist
Lower mid-market private equity firm NorthEdge has completed its investment into life sciences marketing agency, ramarketing, to support rapid service expansion and increased international presence.
North-East headquartered ramarketing employs more than 50 people globally with offices in Newcastle, Manchester and...
News
Samsung Biologics completes full acquisition of Samsung Bioepis
Samsung Biologics announced that it has completed the purchase of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. With the completion of the first payment of USD $1.0 billion pursuant to the terms of the...
News
China Ticks BeiGene PD-1, Can Novartis Bloom In US, Europe
Last year, Novartis chose to purchase its way into the arena after the failure of its PD-1/L1 candidate, spartalizumab. So it reached a deal with China's BeiGene, paying $650 million up front and promising $1.55 billion in milestone payments in...
News
Kings College Uses COVID-19 Tech To Treat Heart Attacks
King's College London, a public research university, is using messenger RNA (mRNA) technology to battle the physiological effects of cardiac arrest in the hopes of developing the world's first heart attack treatment. The technology has the ability to reverse...
News
Indian Pharma Must Aim Generics- Commerce Industry Minister
To become self-reliant, Union Commerce and Industry Minister of India, Piyush Goyal advised the domestic pharmaceutical sector to develop its generic medicine segment and provide greater synergy between input and output of products. Goyal, speaking at an event organised by the...
News
Bora Pharmaceuticals to expand operations with $10m+ investment
Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario.
The company’s CEO, Bobby Sheng, said the expansion,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read